Results 91 to 100 of about 1,213 (179)
ABO and Rh Hemolytic Disease of the Fetus and Newborn
Hemolytic disease of the fetus and newborn (HDFN) is a blood disorder in which red blood cells are destroyed faster, leading to anemia. Our study focused on immune-mediated HDFN. The study included 86 newborns with HDFN. Samples were provided to two clinics in Georgia. Coombs tests were performed to confirm the presence of HDFN.
Shorena Gabaidze +6 more
openaire +1 more source
Schematic diagram illustrating the potential mechanisms and core molecules contributing to the development of PE via mediating pyroptosis: focus on trophoblasts and endothelial cells. Pyroptosis of trophoblast cells in the placenta of preeclampsia not only inhibits its invasion, migration, and differentiation, causing local infiltration and ...
Xianyi Zhou +5 more
wiley +1 more source
Severe cholestasis in neonates with hemolytic disease of the fetus and newborn - a case report
Hemolytic disease of the fetus and newborn (HDFN) may cause severe cholestasis with direct bilirubin concentrations reaching up to 50 times the upper limit of normal.
Natalia Mazanowska +9 more
core +1 more source
Introduction: Many erythrocyte antibodies have been reported to cause hemolytic disease of the fetus and newborn (HDFN), but Lutheran (LU) alloantibodies are normally not involved in HDFN.
Elke Weinig +4 more
doaj +1 more source
Abstract Objective To describe the use of the WOICE tool for assessing non‐severe maternal morbidities among pregnant and postpartum women with hypertensive disorders. Methods Secondary analysis of a previously published cross‐sectional study performed in Brazil, with the inclusion of women with hypertensive disorders (pre‐eclampsia, chronic ...
Stephanie Pabón Lozano +6 more
wiley +1 more source
Maternal IgG in hemolytic disease of the fetus and newborn-ABO incompatibility
BACKGROUND Hemolytic disease of the fetus and newborn (HDFN) is a type of anemia in the fetus or newborn, characterized by anemia, jaundice, hyperbilirubinemia, and brain damage. IgG is the only antibody that can cross the placenta. The IgG subtypes have
Wibowo, Heri +2 more
core +1 more source
Synergistic Regulation of Biomaterials and Macrophages: A Novel Paradigm in Immunotherapy
Bioengineered materials mediating the modulation of macrophage plasticity and inflammatory signals in the tumor microenvironment effectively remodel immunoregulatory states, boost antitumor immunity, and promote tissue repair, achieving synergistic therapeutic outcomes.
Jiayu Zhang +16 more
wiley +1 more source
ABO hemolytic disease of the fetus and newborn (HDFN) generally occurs due to transplacental passage of maternal IgG ABO antibodies causing fetal and newborn red cell hemolysis.
V. K. Nayana +5 more
doaj +1 more source
ABSTRACT Background Moderate‐to‐severe thrombocytopenia (platelet count < 100 × 109/L) occurs in fewer than 1% of pregnancies, posing management challenges, particularly surrounding eligibility for neuraxial anesthesia. Although recent anesthesia guidelines recommend a platelet threshold ≥ 70 × 109/L, outcomes data applying these recommendations in ...
Mackenzie E. Lemieux, Ming Y. Lim
wiley +1 more source
Noninvasive approach for the management of hemolytic disease of the fetus
Hemolytic disease of the fetus and newborn (HDFN) is due to maternal alloantibodies directed against paternally inherited antigens on fetal red cells, and it is still a problem in affected pregnancies despite the routine use of anti-D immunoglobulin ...
Soothill, PW +3 more
core +1 more source

